Taxotere Settlement & Financial Compensation Information

Taxotere settlementSince lawsuits filed against drug manufacturer Sanofi are still pending, no plaintiff has yet won a Taxotere settlement. However, thousands of plaintiffs seeking a Taxotere settlement report permanent and debilitating hair loss. Nearly two decades passed between Taxotere’s initial approval in 1996 and the new FDA warning issued in December 2015. Patients treated with Taxotere during this time therefore faced permanent hair loss side effect risks without being properly informed. Because the FDA updated the drug’s warning label in December 2015, plaintiffs now accuse Sanofi of failing to properly disclose the permanent hair loss risk to cancer patients given Taxotere (generically known as docetaxel).

Recent Lawsuits May Still Win A Taxotere Settlement

After Erma Spann in Illinois filed the first lawsuit on March 10, 2016, more than 30 additional plaintiffs joined. Due to hair loss allegedly resulting from Taxotere chemotherapy treatment, these plaintiffs now demand justice. In this case, many lawsuits list similar allegations by patients treated with Taxotere for breast and other types of cancers. Because there are striking similarities in a variety of claims filed across different states, the U.S. Judicial Panel on Multidistrict Litigation requested consolidation into a class action lawsuit. Finally, on October 4, 2016, the JPML ordered MDL No. 2740 be prepared for pretrial.

Until the courts rule in Taxotere cases, lawyers are still taking on new clients. Whether filing on your own or as joining the class-action lawsuit still pending, you may be eligible for a Taxotere settlement. Since the statute of limitations in these cases can vary by state, potential litigants should compile a complete medical history. Contact previous health care providers and oncologists who can provide crucial support documentation as soon as possible. Before demanding a Taxotere settlement, have an experienced drug injury attorney review your case.

Generic Docetaxel Patients Seeking a Taxotere Settlement May Now Join MDL

In February 2017, a federal judicial panel issued an extraordinary ruling on the Taxotere MDL. Now, any patients who suffered permanent hair loss after receiving generic docetaxel treatments can also join the Taxotere MDL. If you received a chemo cocktail that included docetaxel, you may qualify for a Taxotere settlement after you join the class action filing.

In the event that you or a loved one suffered permanent hair loss after Taxotere treatment, you may have a case. Significant persistent alopecia (otherwise known as permanent baldness) is defined as non-reversible baldness lasting six months or longer. If you still have no hair regrowth months after finishing chemotherapy, fill out your free Taxotere case review form today. An attorney can evaluate your drug injury claim and determine if you may qualify for compensation.

docetaxel chemo bellwether trials and settlement conferences
generic docetaxel

Generic Docetaxel Hair Loss Victims Can Now Join Taxotere MDL

chemo cap therapy may prevent or reduce hair loss in cancer patients

Scalp-Cooling Chemo Cap Aims to Reduce Cancer Hair Loss

chemo side effects

Breast Cancer Chemo Side Effects: What To Expect

Check your eligibility for compensation.

If you or a loved one experienced permanent hair loss after completing Taxotere or generic docetaxel chemotherapy, you may qualify for compensation from the manufacturer. Request your free case evaluation now to see if you may qualify.